Oct 22, 2026, 4:05 PM EDT · 3 days ago Pulse Biosciences Schedules Third Quarter 2026 Financial Results Conference Call for November 5, 2026
2026-10-14T11:05:12.000Z · 11 days ago Pulse Biosciences announces partnership with Clayman Thyroid Center
Oct 14, 2026, 7:00 AM EDT · 11 days ago Pulse Biosciences Announces Commercial and Clinical Partnership with the Clayman Thyroid Center
2026-10-13T11:45:48.000Z · 12 days ago Pulse Biosciences price target raised to $60 from $35 at Oppenheimer
2026-10-13T11:30:35.000Z · 12 days ago Pulse Biosciences price target raised to $55 from $45 at Mizuho
Oct 9, 2026, 4:05 PM EDT · 16 days ago Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 8, 2026, 7:00 AM EDT · 17 days ago Pulse Biosciences' nPulse™ Technology to be Featured at the 21st Annual International VT Symposium 2026
2026-10-07T11:06:15.000Z · 18 days ago Pulse Biosciences announces NANOPULSE-AF study met enrollment target
Oct 7, 2026, 7:00 AM EDT · 18 days ago Pulse Biosciences Achieves Enrollment Target in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation Treatment
2026-10-06T11:10:10.000Z · 19 days ago Pulse Biosciences price target raised to $58 from $43 at Canaccord
2026-09-23T19:50:10.000Z · 4 weeks ago Pulse Biosciences management to meet virtually with Freedom Capital
2026-09-15T11:10:51.000Z · 5 weeks ago Pulse Biosciences announces two milestones in PRECISE-BTN study
Sep 15, 2026, 7:00 AM EDT · 5 weeks ago Pulse Biosciences Completes Enrollment in the PRECISE-BTN Clinical Study Evaluating the nPulse™ Vybrance™ Percutaneous Electrode System for Symptomatic Benign Thyroid Nodules
2026-09-04T11:10:32.000Z · 7 weeks ago Pulse Biosciences announces inducement grants under Nasdaq listing rule
2026-08-18T11:10:42.000Z · 2 months ago Pulse Biosciences announces inducement grants under Nasdaq listing rule
2026-08-10T11:20:41.000Z · 2 months ago Pulse Biosciences price target raised to $43 from $32 at Canaccord
2026-08-10T11:20:36.000Z · 2 months ago Pulse Biosciences price target raised to $45 from $30 at Mizuho
Aug 6, 2026, 4:05 PM EDT · 2 months ago Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results
Jul 30, 2026, 4:05 PM EDT · 2 months ago Pulse Biosciences to Present at Canaccord Genuity's 46th Annual Growth Conference
Jul 29, 2026, 7:00 AM EDT · 2 months ago Pulse Biosciences Surpasses Enrollment Midpoint in NANOPULSE-AF IDE Pivotal Study
Jul 21, 2026, 4:05 PM EDT · 3 months ago Pulse Biosciences Schedules Second Quarter 2026 Financial Results Conference Call for August 6, 2026
Jun 10, 2026, 7:00 AM EDT · 4 months ago Pulse Biosciences, Inc. Announces Planned Redemption of Warrants
May 27, 2026, 4:05 PM EDT · 5 months ago Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026
May 12, 2026, 7:00 AM EDT · 5 months ago ATM Equity Purchases by Pulse Biosciences' Co-Chairmen Total Approximately $13.3 Million
May 8, 2026, 7:00 AM EDT · 5 months ago Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference
May 4, 2026, 7:00 AM EDT · 5 months ago Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results
Apr 25, 2026, 1:00 PM EDT · 6 months ago Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026
Apr 20, 2026, 7:00 AM EDT · 6 months ago Pulse Biosciences' nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting
Apr 7, 2026, 7:00 AM EDT · 6 months ago Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation
Apr 2, 2026, 4:05 PM EDT · 6 months ago Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference
Mar 17, 2026, 7:00 AM EDT · 7 months ago Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data
Mar 12, 2026, 7:00 AM EDT · 7 months ago Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology
Mar 9, 2026, 7:00 AM EDT · 7 months ago Pulse Biosciences Announces Clinical Data From nPulse™ Vybrance™ System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation
Mar 5, 2026, 7:00 AM EST · 7 months ago Pulse Biosciences to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
Mar 4, 2026, 7:00 AM EST · 7 months ago Pulse Biosciences' nPulse™ Vybrance™ System to be Featured in Multiple Presentations at the North American Society for Interventional Thyroidology Meeting
Feb 20, 2026, 7:00 AM EST · 8 months ago Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference
Feb 19, 2026, 4:05 PM EST · 8 months ago Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2025 Financial Results
Feb 5, 2026, 7:00 PM EST · 8 months ago Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium
Feb 4, 2026, 4:05 PM EST · 8 months ago Pulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026
Feb 3, 2026, 7:00 AM EST · 8 months ago Pulse Biosciences' nPulse™ Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium
Jan 9, 2026, 7:00 AM EST · 9 months ago Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors
Jan 6, 2026, 7:00 AM EST · 9 months ago Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium
Dec 29, 2025, 4:05 PM EST · 10 months ago Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
Dec 18, 2025, 7:00 AM EST · 10 months ago Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation
Dec 9, 2025, 7:00 AM EST · 10 months ago Pulse Biosciences, Inc. Announces Initiation of Research Collaboration for the Treatment of Benign and Malignant Thyroid Tumors with nPulse™ Technology
Nov 6, 2025, 4:05 PM EST · 11 months ago Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences
Nov 5, 2025, 4:05 PM EST · 11 months ago Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
Oct 24, 2025, 7:00 AM EDT · 1 year ago Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study
Oct 22, 2025, 4:05 PM EDT · 1 year ago Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025
Oct 10, 2025, 7:00 AM EDT · 1 year ago Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting
Oct 7, 2025, 7:00 AM EDT · 1 year ago Pulse Biosciences Announces Clinical Data Highlighting its nPulse™ Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting
Sep 10, 2025, 7:00 AM EDT · 1 year ago Pulse Biosciences' nPulse™ Technology to be Featured at the American Thyroid Association 2025 Annual Meeting
Sep 8, 2025, 7:00 AM EDT · 1 year ago Pulse Biosciences Announces FDA IDE Approval to Initiate its nsPFA Cardiac Surgery System Study for the Treatment of Atrial Fibrillation
Sep 2, 2025, 7:00 AM EDT · 1 year ago Pulse Biosciences Announces First Successful Procedures in PRECISE Benign Thyroid Nodule (BTN) Study
Aug 26, 2025, 7:00 AM EDT · 1 year ago Pulse Biosciences Announces Publication of First-In-Human Data for Treatment of Benign Thyroid Nodules in the Journal Thyroid
Aug 12, 2025, 4:05 PM EDT · 1 year ago Pulse Biosciences Reports Business Updates and Second Quarter 2025 Financial Results
Aug 1, 2025, 7:00 AM EDT · 1 year ago Pulse Biosciences To Present at the 45th Canaccord Genuity Annual Growth Conference
Jul 29, 2025, 4:05 PM EDT · 1 year ago Pulse Biosciences Schedules Second Quarter 2025 Business Updates and Financial Results Conference Call for August 12, 2025
May 8, 2025, 4:05 PM EDT · 1 year ago Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results